AJANTA PHARMA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA Quarterly Results    (AJPH)

Here are the latest quarterly results of AJANTA PHARMA. For more details, see the AJANTA PHARMA financial fact sheet and AJANTA PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

AJANTA PHARMA Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m6,5126,8206,6827,1597,4877,5687,4808,848 
Other income Rs m146567131495525326295 
Turnover Rs m6,6597,3876,8137,2087,5427,5947,8069,143 
Expenses Rs m4,6525,3064,4504,4175,0714,9745,2786,220 
Gross profit Rs m1,8561,4882,2322,7432,4172,5942,2022,628 
Depreciation Rs m236260280283291306309315 
Interest Rs m163616152626154 
Profit before tax Rs m1,7511,7592,0672,4922,1552,2882,2052,604 
Tax Rs m676467589790388695467645 
Profit after tax Rs m1,0761,2921,4781,7021,7661,5931,7381,959 
Gross profit margin %28.521.833.438.332.334.329.429.7 
Effective tax rate %38.626.628.531.718.030.421.224.8 
Net profit margin %16.518.922.123.823.621.023.222.1 
Diluted EPS Rs 12.4 14.9 17.1 19.7 20.4 18.4 20.1 22.6  
Diluted EPS (TTM) Rs NA 54.0 57.9 64.1 72.1 75.6 78.6 81.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

Read: AJANTA PHARMA 1QFY22 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   SUN PHARMA    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    

Compare AJANTA PHARMA With:   SUN PHARMA    AUROBINDO PHARMA    CIPLA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    



Today's Market

Sensex Pares Losses to Trade Flat, Nifty Near 17,150; Axis Bank Jumps 5% Post Stellar Q3 Results(10:30 am)

Asian stock markets are trading sharply lower today with investors remaining cautious over geopolitical risks linked to Ukraine and the US Federal Reserve's decision later this week.

Views on news

AJANTA PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 17.6% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 17.6% YoY). Sales on the other hand came in at Rs 7 bn (up 11.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of AJANTA PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY21); Net Profit Up 23.3% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 23.3% YoY). Sales on the other hand came in at Rs 8 bn (up 11.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 25, 2022 11:37 AM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA - MYLAN COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS